CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)

CUSIP: 23255M105

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COMMON STOCK
Shares outstanding
4,330,313
Total 13F shares
22,941,416
Share change
+5,248,514
Total reported value
$139,523,457
Price per share
$6.08
Number of holders
65
Value change
+$32,049,269
Number of buys
27
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 23255M105?
CUSIP 23255M105 identifies CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
63%
2,744,107
$16,218,000 30 Jun 2020
13F
EcoR1 Capital, LLC
13F
Company
63%
2,742,276
$16,207,000 30 Jun 2020
13F
MFN Partners Management, LP
13F
Company
56%
2,427,677
$14,348,000 30 Jun 2020
13F
Artal Group S.A.
13F
Company
43%
1,841,584
$10,883,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
36%
1,566,862
$9,261,000 30 Jun 2020
13F
Slate Path Capital LP
13F
Company
28%
1,196,063
$7,069,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
26%
1,121,604
$6,629,000 30 Jun 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
14%
619,522
$3,661,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
12%
500,080
$2,955,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
7.3%
316,153
$1,868,000 30 Jun 2020
13F
Eversept Partners, LP
13F
Company
5.7%
247,663
$1,463,688 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
5.7%
246,416
$1,456,000 30 Jun 2020
13F
TRUSTCORE FINANCIAL SERVICES, LLC
13F
Company
4.6%
198,106
$1,171,000 30 Jun 2020
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
3.5%
153,109
$905,000 30 Jun 2020
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
3.5%
150,390
$889,000 30 Jun 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
3.3%
142,458
$842,000 30 Jun 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
3.3%
142,009
$839,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3%
129,765
$767,000 30 Jun 2020
13F
COLONY GROUP LLC
13F
Company
2.4%
102,884
$608,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
2.1%
88,965
$526,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2%
85,000
$502,000 30 Jun 2020
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.8%
78,798
$466,000 30 Jun 2020
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
1.4%
61,000
$361,000 30 Jun 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.4%
60,482
$357,000 30 Jun 2020
13F
AWH Capital, L.P.
13F
Company
1.2%
52,390
$310,000 30 Jun 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.86%
37,214
$220,000 30 Jun 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.83%
35,770
$211,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.8%
34,658
$205,000 30 Jun 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.79%
34,099
$202,000 30 Jun 2020
13F
Invesco Ltd.
13F
Company
0.79%
34,001
$201,000 30 Jun 2020
13F
Brian C. Broderick
13F
Individual
0.74%
32,175
$190,000 30 Jun 2020
13F
FIRST TRUST ADVISORS LP
13F
Company
0.73%
31,721
$187,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.72%
31,195
$184,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.66%
28,398
$168,000 30 Jun 2020
13F
Russell Investments Group, Ltd.
13F
Company
0.64%
27,766
$163,000 30 Jun 2020
13F
Ensign Peak Advisors, Inc
13F
Company
0.62%
26,941
$159,000 30 Jun 2020
13F
TD ASSET MANAGEMENT INC
13F
Company
0.59%
25,342
$150,000 30 Jun 2020
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.57%
24,616
$145,481 30 Jun 2020
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.54%
23,428
$138,000 30 Jun 2020
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.5%
21,579
$128,000 30 Jun 2020
13F
Alambic Investment Management, L.P.
13F
Company
0.49%
21,065
$124,000 30 Jun 2020
13F
PDT Partners, LLC
13F
Company
0.4%
17,268
$102,000 30 Jun 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.37%
16,137
$95,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.36%
15,638
$93,000 30 Jun 2020
13F
Verition Fund Management LLC
13F
Company
0.35%
15,000
$89,000 30 Jun 2020
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.33%
14,177
$84,000 30 Jun 2020
13F
Paloma Partners Management Co
13F
Company
0.32%
13,762
$81,000 30 Jun 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.31%
13,545
$80,000 30 Jun 2020
13F
BARCLAYS PLC
13F
Company
0.3%
13,183
$77,000 30 Jun 2020
13F
SG Americas Securities, LLC
13F
Company
0.29%
12,528
$74,000 30 Jun 2020
13F

Institutional Holders of CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) as of Q3 2020

As of 30 Sep 2020, CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,941,416 shares. The largest 10 holders included Slate Path Capital LP, EcoR1 Capital, LLC, FMR LLC, MFN Partners Management, LP, Artal Group S.A., VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 65 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
67
Q3 2020 holders
65
Holder diff
-2
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .